Limited mid-term durability of 12A/LX Mitroflow bioprosthesis has been reported. Aim of the study was to ascertain the pathologic substrates and possible mechanisms of structural valve deterioration in explants from animals and humans.
THE PATHOLOGY OF EARLY FAILURE IN MITROFLOW PERICARDIAL VALVE BIOPROSTHESIS (12A/LX)
Barbera, Mila Della;Valente, Marialuisa;Basso, Cristina;Pettenazzo, Elena;Thiene, Gaetano
2021
Abstract
Limited mid-term durability of 12A/LX Mitroflow bioprosthesis has been reported. Aim of the study was to ascertain the pathologic substrates and possible mechanisms of structural valve deterioration in explants from animals and humans.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
